Gregory Schreiber

Gregory Schreiber currently serves as VP of IP Strategy & Licensing at EXUMA Biotech, where responsibilities include shaping technology and legal strategies for novel gene and cell therapies aimed at treating cancer and autoimmune disorders. Previous experience includes a role as Senior Director of Academic Alliances & Technology Licensing at Intrexon Corporation, contributing to the development of biologically-based products. Earlier in their career, Gregory held the position of Associate Director of Corporate Development at Life Technologies and also served as Associate Director at Johns Hopkins Technology Transfer. Gregory Schreiber earned a Ph.D. in Immunology from Washington University in St. Louis and holds a degree from the University of California, Berkeley.